State Ledger
Company profile

Marker Therapeutics, Inc. CIK 1094038

Ticker
MRKR (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Houston, TX 77021
Fiscal year end
2025 (FY)
Market Data
Close
$1.01
Change
+$0.03
Change %
3.26%
Volume
635

MRKR · trading date Oct 12, 2026 · previous close $0.97 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$12.16M
Total assets
$19.07M
Total liabilities
$2.27M
Stockholders' equity
$16.80M
Cash & equivalents
$16.07M
Operating income
-$12.89M
Operating cash flow
-$12.01M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-18. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
11.9%
Equity / assets
88.1%
CapEx / revenue
—
Operating cash flow / net income
0.99×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$12.16M $19.07M $2.27M $16.80M
2024 — -$10.73M $22.02M $3.46M $18.56M
2023 — -$8.24M $17.13M $3.07M $14.05M
2022 — -$29.93M $34.42M $14.82M $19.60M
2021 $0 -$41.88M $68.14M $24.15M $43.99M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-14
Financials filed via
Form 10-K
filed 2026-03-18

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Houston, TX 77021
2450 HOLCOMBE BLVD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:55 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Texas — Public Companies